MOTIVATE-CW

  • Research type

    Research Study

  • Full title

    Implementation of a clinical exercise physiologist-led, mobile health supported, prehabilitation and rehabilitation service for people awaiting treatment for liver cancer or liver transplantation

  • IRAS ID

    370726

  • Contact name

    Matthew Cocks

  • Contact email

    m.s.cocks@ljmu.ac.uk

  • Sponsor organisation

    Liverpool John Moores University

  • Clinicaltrials.gov Identifier

    26/NW/0122, North West - Greater Manchester West

  • Duration of Study in the UK

    1 years, 11 months, 31 days

  • Research summary

    Exercise-based prehabilitation and rehabilitation can improve short- and long-term health and wellbeing outcomes in people with cancer, including those with liver cancer. However, this population often presents with complex clinical and supportive care needs, requiring a highly personalised and holistic approach. Delivering such services within the constraints of routine NHS care is therefore challenging.

    In response, Liverpool University Hospitals NHS Foundation Trust (LUHFT) and The Clatterbridge Cancer Centre NHS Foundation Trust (CCC), in partnership with Liverpool John Moores University (LJMU), have developed a clinical exercise physiologist (CEP)–led, mobile health (mHealth)–supported exercise-based prehabilitation and rehabilitation service for people with liver cancer awaiting treatment.

    This study will evaluate implementation of the service, examining its feasibility within routine care pathways and its effectiveness in improving patient outcomes. A nested process evaluation will provide contextual insight into how the service is delivered and experienced, informing ongoing refinement.

    This multi-centre implementation trial will collect data from patients enrolled in the service between April 2026 and March 2028. Data sources will include anonymised clinical data extracted from patient records held by LUHFT, CCC and the LJMU clinic, alongside questionnaire and interview data collected from consenting patients.

    In line with Medical Research Council guidance on process evaluation and the RE-AIM implementation framework, the study will assess Reach, Effectiveness, Adoption, Implementation and Maintenance.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    26/NW/0122

  • Date of REC Opinion

    3 Jun 2026

  • REC opinion

    Further Information Favourable Opinion